Quimiorradiación concomitante con gemcitabina y cisplatino
en cáncer de cérvix uterino localmente avanzado
Toxicidades
50
45
40
35
30
Leve
Severa
25
20
15
10
5
Pr
oc
ti t
is
iti s
Ra
di
od
er
m
ito
Vó
m
Di
ar
re
a
fe
br
il
Ne
ut
ro
p
en
ia
en
ia
Tr
om
bo
cit
op
ia
An
em
Ne
ut
ro
p
en
ia
0
Dueñas-González A, Zarba JJ, Alcedo JC, et al. A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis)
and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA carcinoma
of the cervix. J Clin Oncol 27:18s, 2009 (suppl; abstr CRA5507)
Quimiorradiación
concomitante con
gemcitabina y
cisplatino en
cáncer de cérvix
uterino
localmente
avanzado
Dueñas-González A, Zarba JJ,
Alcedo JC, et al. A phase III
study comparing concurrent
gemcitabine (Gem) plus
cisplatin (Cis) and radiation
followed by adjuvant Gem plus
Cis versus concurrent Cis and
radiation in patients with stage
IIB to IVA carcinoma of the
cervix. J Clin Oncol 27:18s,
2009 (suppl; abstr CRA5507)
%
LemaTeachFiles® - 2009
0,8
2,8
Proctitis
Quimiorradiación
concomitante con
gemcitabina y cisplatino en
cáncer de cérvix uterino
localmente avanzado
11
Radiodermitis
7,7
Vómito
17
Diarra
Leve
Neutropenia febril 1,5
5,8
Trombocitopenia
Severa
0,8
0,8
7,7
Anemia
1,5
45
Neutropenia
0
10
20
6
30
40
50
60
Dueñas-González A, Zarba JJ, Alcedo JC, et al. A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis)
and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA carcinoma
of the cervix. J Clin Oncol 27:18s, 2009 (suppl; abstr CRA5507)
Descargar

Diapositiva 1